Hospital News, Industry News, Press, Tru-D News, Tru-D Technology, Uncategorized

From Duke Health: UVC Light Helps Hospitals Fight Drug-Resistant Superbugs

From Clinical Practice Today by Duke Health:

Read More
Posted 05.10.17
  • Share

Industry News, Press, Studies, Tru-D News, Tru-D Technology

Tru-D SmartUVC Proven to Reduce Bioburden in Operating Rooms

A recent study published in the American Journal of Infection Control, Ultraviolet-C light as a means of disinfecting anesthesia workstations, demonstrated Tru-D SmartUVC’s ability to reduce bioburden on anesthesia workstations. In the study, UVC disinfection greatly influenced bioburden reduction on high-touch, complex medical equipment surfaces contaminated with three (3) organisms

Read More
Posted 05.04.17
  • Share

Tru-D News, Uncategorized

Tru-D Hires Clinical Affairs Director

Image of Ralph Taylor

Tru-D SmartUVC, a leader in the ultraviolet (UV) disinfection space, has hired a Director of Clinical Affairs. Ralph Taylor, RN, MSN, MHA, CNOR has joined the Tru-D team to expand the success of the company’s approach to enhanced UV disinfection throughout the U.S. As Director of Clinical Affairs, Taylor will

Read More
Posted 05.02.17
  • Share

Industry News, Studies, Tru-D News, Tru-D Technology, Uncategorized

BETR-D Study Shows 11% C. diff Reduction

Shield Design with 11% Hospital C. Diff Reduction

The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study is the first and only randomized clinical trial on UV disinfection. The study’s primary outcome showed that enhanced terminal room disinfection strategies that utilized Tru-D reduced the risk of acquisition and infection by a cumulative 30 percent among patients who entered the

Read More
Posted 04.26.17
  • Share

Hospital News, Industry News, Tru-D News, Tru-D Technology, Uncategorized

Q&A With Chesapeake Regional Healthcare

Chesapeake Regional Healthcare was one of the nine hospitals that participated in the CDC-funded, $2M Benefits of Enhanced Terminal Room-Disinfection (BETR-D) randomized clinical trial on UV disinfection. The study was conducted from 2012-2014 throughout the Duke Infection Control Outreach Network, and, during that time, CRH saw a 12 percent reduction in its

Read More
Posted 04.19.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »